Jaclyn Scott

Jaclyn Scott, PhD, is an experienced consultant at Global Regulatory Writing & Consulting, Inc., specializing in strategic regulatory CMC guidance for complex biologics, including vaccines and cell therapies, since October 2020. Prior roles include significant contributions in CMC regulatory affairs at Takeda Vaccines, where leadership was provided for various vaccine development phases, and a regulatory affairs specialist position at Inviragen, where key regulatory submission documents were reviewed and prepared. Jaclyn Scott also has a strong background in microbiology and virology, with a PhD from Colorado State University, experience in academic research, and participation in advanced vaccine studies leading to publications and patents.